Health X Platform Ltd Q3 FY26 Earnings Analysis

Published 1 Jun 2026 | Healthcare Services | Market Cap: ₹977 Cr

Price

295

Market Cap

₹977 Cr

P/E Ratio

508.6

Earnings Summary

Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability. Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin. - SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency. - The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years. - PAT turned positive at Rs.

📊 Revenue & Sales Performance

  • Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability.
  • SastaSundar B2C business is expected to grow around 100% year-on-year from this year to next.
  • January to March is expected to be one of the best quarters, with recent growth trends positive.
  • Expansion plans include new warehouses in Lucknow, Udaipur, and capacity doubling in existing facilities to support growth across Eastern, Northern, and North-Eastern India.
  • The JITO generic brand is projected to significantly increase revenue and gross margin by tapping into a rapidly growing generic medicine market.
  • The company is confident of achieving EBITDA positive performance in Retailer Shakti by FY27 and contribution margin positivity in SastaSundar B2C by the same period.
  • Overall, the company focuses on scaling revenue with improved operating efficiency and technological investments for sustainable long-term growth.

📈 Profitability & Margins

  • Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin.
  • SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency.
  • The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years.
  • PAT turned positive at Rs. 11 crores in 9-month FY26 vs. loss of Rs. 151 crores in the previous year, supported by improved operating efficiency and other income.
  • January month Retailer Shakti reported EBITDA positivity, indicating a strong operational turnaround.
  • Sustained focus on technology investment and expansion in categories/geographies expected to drive future operating leverage and profitability improvements starting FY27.

🏗️ Capital Expenditure Plans

  • Investing ~Rs. 10 crores in West Bengal for an additional 80,000 sq ft warehouse capacity (completion in ~6 months).
  • Planning a new warehouse in Noida; timeline about 1.5 years; also expansions in Guwahati, Lucknow, Udaipur (2-year horizon).
  • Allocated Rs. 25 crores annually for AI and technology development for both SastaSundar and Retailer Shakti platforms.
  • Rs. 150 crores earmarked for new technology building, with Rs. 50-60 crores already spent; remaining to be funded from treasury income over next 2-3 years.
  • Rs. 10 crores invested in Retail Air, an AI-driven SaaS platform for retailers, to be launched in 3-4 months.
  • JITO brand distribution being scaled without additional capital outlay by leveraging existing warehouses, distribution, and technology.
  • Overall capex focused on warehouse expansion, AI automation, and technology platforms to enhance supply chain and customer experience.

💰 Fundraising & Capital Structure

  • There is no explicit mention of any ongoing or planned fundraising through debt or equity in the provided pages.
  • The management emphasizes strong capital efficiency and treasury income supporting growth, indicating a focus on self-sustained funding.
  • The company has significant cash reserves (~Rs. 500 crores combined treasury as of March 2025) and aims to use these funds for growth.
  • A merger and demerger process is planned for the next financial year, but no direct reference to raising funds via this route.
  • The company has conducted a buyback of Rs. 100 crores from Mitsubishi, indicating cash utilization for shareholder returns rather than new fundraising.
  • The focus remains on organic growth, technology investment, and capital-efficient expansion without explicit plans for new external funding.

📋 Order Book & Pipeline

The document does not explicitly mention any current or expected order book or pending orders for SastaSundar Ventures Limited. However, relevant insights related to order flow and growth include: - Retailer Shakti guarantees next-day delivery, enabling retailers to reduce inventory from 40 days to 10 days. - The company receives 100% orders through digital channels; over 50% via the app, and the rest via HealthBuddy service centers. - Q3 FY26 saw a 10% quarter-on-quarter growth, with confidence expressed in sustaining 30% CAGR over the next 5-10 years for Retailer Shakti. - SastaSundar B2C is progressing towards positive contribution margin, expecting growth driven by technology and increased retailer reach. - JITO brand sales have started recently and expected to contribute 2-3% of revenue next year, scaling to 5-10% in 3-4 years. No explicit figures on orderbook or pending orders are provided.

Key Metrics

Frequently Asked Questions

What were Health X Platform Ltd Q3 FY26 results?

Retailer Shakti aims to grow at a CAGR of +30% year-on-year for the next 5-10 years, with some quarter-to-quarter variability. Retailer Shakti is progressing towards EBITDA break-even by Q4 FY26 and expected to deliver sustainable EBITDA positive performance in FY27, with anticipated 1% EBITDA margin. - SastaSundar B2C is progressing towards contribution margin positive in FY27 with improved operating leverage driven by higher order density and customer acquisition efficiency. - The company targets around 30% year-on-year CAGR growth for Retailer Shakti over the next 5-10 years. - PAT turned positive at Rs.

What is Health X Platform Ltd share price analysis?

Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.

Is Health X Platform Ltd planning capital expenditure?

Investing ~Rs.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Health X Platform Ltd's management said in earlier quarters

Others in Healthcare Services this season